KRAS mutations have been reported in up to 35%-45% of CRC, with the majority of mutations occurring in exon 2 codon 12.22,23 In the retrospective arm of our study, the prevalence of KRAS mutations was consistent with previous randomized trials. Here, KRAS is linked to colorectal carcinoma.